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Recessive mutations in the desmosomal plaque protein
plakophilin 1 (PkP1) underlie ectodermal dysplasia/skin
fragility syndrome (MIM 604536).We undertook an im-
munohistochemical and quantitative electron micro-
scopic examination of suprabasal desmosomes from 4
skin samples from 3 PkP1 de¢cient patients, an unaf-
fected carrier with a PKP1 heterozygous acceptor splice
site mutation and 5 healthy control subjects. Desmoso-
mal plaque size (450 desmosomes per individual) and
frequency (420 high power ¢elds, HPF) were assessed.
Compared with controls, desmosomes were reduced
dramatically both in size (49%) and frequency (61%) in
the lower suprabasal layers (LSB) in PkP1 null patients
(Po0.01). In the LSB compartment of the heterozygous
carrier, corresponding reductions were 37% and 20%,
respectively (Po0.01). Surprisingly, the PkP1 null pa-
tient’s upper suprabasal layer, (USB), desmosome size
was larger (59%, Po0.01) than the control value, and
showed increased desmoglein 1 and PkP2 USB staining.
The USB desmosome frequency in PKP1 null patients
was similar to the LSB compartment (but reduced by
43% compared to USB controls). The carrier showed
no di¡erence in the USB desmosome size and fre-
quency compared with the controls (P40.05). The
PKP1 null patients showed poorly developed inner and
outer desmosomal plaques. Thus, both the patients
and una¡ected carrier showed reductions in the LSB
desmosome size and number; despite only PkP1
null patients exhibiting any phenotype. These ¢ndings
attest to the molecular recruiting and stabilizing
roles of PkP1 in desmosome formation, particularly
in the LSB compartment. Key words: cell-cell adhesion/
desmosome/electron microscopy/genodermatosis/intermediate ¢la-
ments. J Invest Dermatol 121:96 ^103, 2003
D
esmosomes are found at sites of cell-cell attachment
between adjacent epithelial cells, including epider-
mal keratinocytes. Structurally, epidermal desmo-
somes are usually small (200^350 nm), electron-
dense, symmetrical, disk-like structures, which link
the keratin intermediate ¢lament systems within cells to the plas-
ma membrane and to adjacent cells (Kelly, 1966; Kelly and Shien-
vold, 1976). Desmosomal structure is made more complex by the
presence, within each keratinocyte, of a clear two-plaque struc-
ture (inner and outer plaques) and by the close association of ker-
atin intermediate ¢laments with the cytoplasmic surface of the
inner plaque (Legan et al, 1992; Garrod, 1993).
Desmosomes express a cell-type- and di¡erentiation-speci¢c
pattern of molecular components, the most important of which
are the desmosomal cadherins of the desmocollin and desmoglein
families (Schmidt et al, 1994; Kurzen et al, 1998). These transmem-
brane cadherin molecules are then, in turn, indirectly but sequen-
tially linked by proteins of the armadillo (Bornslaeger et al, 2001)
and plakin protein families to the keratin intermediate ¢lament
cytoskeleton network (Buxton and Magee, 1992; Green and
Jones, 1996). Important members of the armadillo protein family
include plakoglobin, b-catenin and plakophilin isoforms, plako-
philins (PkP) 1, 2 (Heid et al, 1994; Mertens et al, 1996; Schmidt
et al, 1997; Kurzen et al, 1998), and 3 (Schmidt et al, 1999; Bonne
et al, 1999), and PkP 4/p0071 (Hatzfeld and Nachtsheim, 1996).
PkP1, PkP2, and PkP3 are expressed within various layers of the
epidermis and some of their isoforms show a remarkable dual
localization at the desmosome and cell periphery, within the cy-
toplasm and cell nucleus. Their functions are thought to bridge
cytoskeletal cell-cell interactions and they are possibly involved
in nuclear signaling (see the review by Hatzfeld, 1999).
A number of congenital diseases involving desmosomal com-
ponents a¡ecting the epidermis have been identi¢ed (see the
review by McMillan and Shimizu, 2001). Patients have been de-
scribed with autosomal recessive defects in the gene encoding the
desmosomal component PkP1 (McGrath et al, 1997; 1999a;
McGrath, 1999). Defects in the PkP1 gene (PKP1) lead to ectoder-
mal dysplasia and skin fragility that is characterized by skin ero-
sions, dystrophic nails, sparse hair, and a painful, debilitating
thickening and cracking of the palms and soles. PkP1 is a small,
intracellular 80 kDa desmosomal plaque component that is ex-
pressed in the mid-layers of strati¢ed human epithelium includ-
ing the skin and within the human hair follicle (Moll et al, 1997;
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Kurzen et al, 1998). The role of PkP1 is thought to be to aid robust
keratinocyte adhesion by stabilizing or recruiting other desmoso-
mal components (Hatzfeld et al, 2000; Bornslaeger et al, 2001).
PkP1 binds desmoglein 1, desmocollin 1, and desmoplakin in vitro
(Mathur et al, 1994; Hatzfeld et al, 2000; Bornslaeger et al, 2001).
PkP1 also binds keratin ¢lament monomers in vitro but has not
been shown to bind polymerized ¢laments and, given its position
in the desmosome, is unlikely to directly interact with the keratin
bundles in the keratinocyte cytoplasm adjacent to the desmosome
(North et al, 1999; Bornslaeger et al, 2001).
There are several quantitative reports concerning desmosome
size and number in normal human skin (Snell, 1966; Raknerud,
1975; Caputo and Peluchetti, 1977; Hino et al, 1981). For the pur-
poses of this study, skin was obtained from PkP1-de¢cient pa-
tients with the ¢rst three reported defects in PkP1, and included
an una¡ected PKP1 splice site mutation carrier who showed ab-
solutely no clinical signs of skin fragility (McGrath et al, 1997;
1999b;Whittock et al, 2000). The aim of this study was to deter-
mine in detail what e¡ects the disruption in PkP1 expression has
on keratinocyte adhesion and desmosomal size and number in
PkP1-de¢cient patients’epidermis and the PKP1mutationcarrier’s
epidermis. We have precisely quanti¢ed the changes in speci¢c
desmosomal parameters within two di¡erent epidermal compart-
ments, to con¢rm the reported role that PkP1 has in the mainte-
nance of desmosome plaque size and cell adhesion. We have
performed immunohistochemistry to detect critical secondary
changes in desmosome component expression resulting from the
loss of PkP1 expression and cell adhesion in the mid-epidermal
layers.
METHODS
Skin samples Skin biopsy specimens were obtained from the ¢rst three
reported patients and a PKP1mutation carrier as part of routine diagnostic
procedures (seeTable I for patients’ biopsy details). In all cases, the biopsies
were performed with the patients’or guardians’ informed consent and with
the relevant institutional approval for experiments handling human matter
in accordance with Helsinki Principles. Controls were obtained from ¢ve
normal individuals without skin disease (three females and two males, aged
between 15 and 37 y; seeTable I). Biopsies from PkP1-de¢cient patients for
transmission electron microscopy (n¼ 4, cases 1^3) and frozen skin for
cryostat sectioning and indirect immunohistochemistry (n¼ 3, cases 1^3)
were included in this study (see Table I). Only skin for electron
microscopy was available from the una¡ected splice site mutation carrier
(a sibling of the individual in case 3). The clinical diagnosis of skin
fragility syndrome (MIM #604536) was made in each case by at least one
of the reporting authors and the diagnosis was con¢rmed by transmission
electron microscopy and immunohistochemistry (McGrath et al, 1997;
1999b; Whittock et al, 2000). PkP1-de¢cient patients harbored the
following previously reported mutations: case 1, Q304X/1132ins28; case 2,
203-1 G-A/Y71X; case 3, 1233-2 A-T/1233-2 A-T; these in each case
led to an absence of PkP1 protein expression. The una¡ected PkP1
nonsense mutation carrier had the 1233-2 A-T splice site mutation on a
single allele, a situation that is predicted to lead to the expression of some
normal PkP1 protein from the una¡ected allele. PkP2 and PkP3
immunohistochemistry was performed on psoriasis vulgaris and
pemphigus vulgaris patients’ skin samples (n¼ 2) taken from the upper
arm for comparison with PkP1-null skin.
Immuno£uorescence labeling Indirect immuno£uorescence was
performed as previously described (Kennedy et al, 1985) using cryostat skin
sections. To determine desmosomal component expression, epidermal
samples of control adult skin and PkP1-de¢cient cases 1, 2, and 3 were
stained using the following desmosomal antibodies: anti-PkP1 antibody
(PP1-5C2, monoclonal) that recognizes the PkP1 head domain
(undiluted; Progen, Heidelberg, Germany); 11C6 (monoclonal) that
recognizes the PkP1 N-terminus (Kurzen et al, 1998). Mouse monoclonal
anti-PkP2 cocktail mix (undiluted, Progen) (Mertens et al, 1996) and the
monoclonal anti-PkP3 clones 310.10.9.1 and 270.6.3 (undiluted, also from
Progen) (Schmidt et al, 1999) were included in this study. To determine
the PkP2 and PkP3 cytoplasmic and desmosomal localization a modi¢ed
staining protocol was used that included acetone ¢xation (10 min), 0.01%
Triton X100 treatment (10 min), and overnight primary antibody
incubation (Mertens et al, 1996; Hatzfeld et al, 2000). The desmoplakin
antibody 11F5 that recognizes the desmoplakin C-terminus (D. Garrod,
personal communication; monoclonal, diluted 1:10; North et al, 1999);
PG5.1 that recognizes plakoglobin (monoclonal, diluted 1:200; Progen),
the monoclonal 32-2B that recognizes desmoglein 1 cytoplasmic C-
terminal domain (D. Garrod, personal communication; monoclonal,
diluted 1:10; Vilela et al, 1987); 33-3D that recognizes the cytoplasmic
domains of desmogleins 1 and 2 (D. Garrod, personal communication;
monoclonal, diluted 1:10; Krunic et al, 1998), and the monoclonal
antidesmocollin 1a/b (Dsc1-U100, used neat; Progen; Nuber et al, 1996)
were also included.
Sections were either ¢xed in cold acetone (^201C) for 10 min and/or
incubated with 5% normal rabbit sera and 0.01% Triton X100 detergent
in 0.1 M Dulbecco’s phosphate-bu¡ered saline (PBS) for 5 min at 371C.
Sections were incubated with primary antibodies and subsequently with
secondary antibodies conjugated to £uorescein isothiocyanate (FITC;
rabbit antimouse IgG or goat antirabbit IgG; 1:200; Dako, Tokyo, Japan),
both diluted in 3% bovine serum albumin (BSA) in 0.1 M PBS for 30
min at 371C in a darkened, humidi¢ed chamber. The sections were then
mounted in Perma£uor (Thermo Shandon, Pittsburgh, PA) and examined
with a Nikon Optiphot 2 epi£uorescent microscope or an Olympus
Fluoview FV300 confocal microscope (Olympus, Tokyo, Japan) using an
Olympus IX70 inverted microscope. Controls included normal breast and
arm skin and psoriasis vulgaris and pemphigus vulgaris patients’ skin
samples (n¼ 2), with the primary antibody substituted by PBS, myeloma
supernatant, or an irrelevant immunoglobulin isotype, as a negative
control. All experiments were performed in duplicate.
PkP1 image analysis Image analysis was performed by digitizing the
£uorescence slides of either the PP1-5C2 or 11C6 antibodies into black
and white images, and the analysis was performed using the MCID/
M2 image analysis program (Imaging Research, Ontario, Canada).
Rectangular areas (perpendicular to the dermalepidermal junction) on
the PkP1 £uorescence image that included the basal and the corni¢ed cell
layers were then selected and printed, and the total relative image intensity
was plotted against the distance from the dermalepidermal junction
(Fig 1). The digital information was saved and exported into Microsoft
Excel, and each distance from the dermalepidermal junction was
converted to a value between 0% and 100% for graphical manipulation
and a comparison between multiple sample images (n¼ 5).
Electron microscopy Transmission electron microscopy was performed
as described by Eady (1985). Brie£y, the skin specimens were cut into small
pieces and placed in half-strength Karnovsky ¢xative.1 Samples were ¢xed
while on a rotator at room temperature for 4^5 h and then washed in
cacodylate bu¡er. Post¢xation was in osmium tetroxide for 2 h at room
Table I. Summary of the details of the control and
PkP1-de¢cient patients’ skin biopsies
Control or patient number
(mutation genotype)
Sex/Biopsy
age
Biopsy site
Lesional site
Control 1 F/15 y Back No lesions present
Control 2 F/22 y Abdomen No lesions present
Control 3 F/25 y Lower back No lesions present
Control 4 F/33 y Neck No lesions present
Control 5 F/37 y Lower back No lesions present
PKP1-nulla case 1 M/5 y Thigh Perilesional
(Q304X/1132ins28)
PKP1-null case 2 M/2 y Buttock Perilesional
(203-1 G-A/Y71X)
PKP1-null case 3 M/5 y/17 y Arm/Thighb Perilesional
(1233-2 A-T/1233-2 A-T)
Case 3 (mutation carrier) M/15 y Thighb No lesions present
(1233-2 A-T)
aPKP1-null, ectodermal dysplasia/skin fragility syndrome.
bDenotes similar biopsy sites on the thigh of the PkP1-null patient and the
mutation carrier.
1Karnovsky MJA: Formaldehyde-glutoralhyde ¢xative of high osmolar-
ity for use in electron microscopy. J Cell Biol 27:137^138a, 1965.
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temperature. Specimens were dehydrated in a graded ethanol series (15 min
each), stained en bloc in uranyl acetate, and embedded in TAAB 812
resin (TAAB, Aldermaston, UK) via propylene oxide. Semithin sections
(0.5 mm) cut on a Reichert OMU-4 ultramicrotome (Leica, Milton
Keynes, UK) were stained with azure II and methylene blue (Richardson
et al, 1960). Ultrathin sections (80^90 nm) were stained in 50% alcoholic
uranyl acetate (15 min) and lead citrate (5 min) and examined in a Hitachi
H-7100 transmission electron microscope (Tokyo, Japan) with an
accelerating voltage of 75 kV.
Desmosomal morphometry and ultrastructural analysis Electron
micrographs of keratinocyte desmosomes were obtained at a standard
magni¢cation setting of 30,000. A carbon di¡raction grating with 2000
lines per mm was used for calibration purposes and to calculate the ¢nal
magni¢cation. The micrographs were printed at a constant enlargement of
2.2 times, giving a ¢nal magni¢cation of 67,000. Areas that contained
nonkeratinocyte cells or obliquely sectioned desmosomes were excluded
from this study. The length of the desmosomal outer plaque was
measured. For the purposes of standardization, all assessments of
desmosome number, structural features, and size were performed by one
observer (J.R.M.). At least 50 desmosomes were counted for each
individual. Sampling was done by selecting from two areas in the stratum
spinosum (either between the lower suprabasal (LSB) or upper suprabasal
(USB) keratinocytes) where the whole keratinocyte plasma membrane
surface could be continuously surveyed, and a series of adjacent high
power ¢eld (HPF) pictures was taken that included recognizable
desmosomal plaques within both keratinocytes. The LSB layer was
de¢ned as the area between the lateral keratinocyte borders immediately
above the basal layer (see Fig 2a^c for approximate LSB position in
control and a¡ected skin) and the USB layer was de¢ned as the
keratinocyte border immediately beneath the ¢rst (lowest) granular layer
(Fig 2a^c, USB). Overlapping HPF micrographs were used to check the
approximate length of continuous plasma membrane in a given ¢eld of
view (using the MCID/M2 image analysis program; Imaging Research).
This enabled us to make a comparison of desmosome frequency between
two di¡erent ¢elds excluding the possibility of di¡ering overall lengths of
visualized plasma membranes.
The desmosome size in nm (7SEM) and frequency per HPF was
calculated. For each individual, the total mean desmosome size and
frequency was calculated and individual data were grouped together.
Two-way analysis of variance, as described by Altman (1991), and the
Mann^Whitney con¢dence interval tests were performed (with a 99%
con¢dence interval) using the Minitab statistical package (Minitab,
University of Pennsylvania, PA) to compare the respective LSB and USB
mean values of the three groups (the controls, PkP1-null patients, and the
PkP1 mutation carrier).
RESULTS
PkP1 £uorescent image analysis PkP1 staining of normal
human skin using two monoclonal antibodies (PP1-5C2 and
11C6, the latter not shown) demonstrated the highest PkP1
expression levels between the mid-suprabasal keratinocyte layers
(Fig 1a). Figure 1b shows an average image analysis result for
PkP1 intensity from ¢ve selected areas of control epidermis
using the PP1-5C2 antibody.
PkP1-null skin desmosomal antigen expression Comparison
of desmosomal component staining patterns between control
arm and breast skin (n¼ 2) and PkP1-null skin (n¼ 2, cases 1, 2,
or 3) revealed bright suprabasal intercellular PkP1 staining in
control skin (Figs 1a, 2a); however, there was no staining in
ectodermal dysplasia/skin fragility patients’ skin (Fig 2b). PkP2
staining was restricted to the basal keratinocyte cytoplasm in a
di¡use pattern in some but not all samples of control skin (Fig
2c). Basal layer keratinocytes stained with PkP2 in control arm
skin but breast skin failed to react. PkP2 also highlighted outer
sweat duct cells and acrosyringium. In two out of the three
PkP1-null patients’ biopsies (cases 1 and 3) PkP2 showed marked
staining at the peripheral borders of suprabasal keratinocytes
extending into the granular layers (Fig 2d; dashed line
highlights the dermalepidermal junction). PkP2 staining was
not performed in case 2. Interestingly, psoriasis skin (n¼ 2) but
not pemphigus vulgaris skin (n¼ 2) also showed this
upregulated suprabasal PkP2 expression (data not shown). PkP3
staining was restricted to the keratinocyte cytoplasm and
peripheral border in control skin (Fig 2e) and showed a similar
staining pattern in PkP1-null patients’ skin (Fig 2f). Plakoglobin
staining showed occasional focal disruption corresponding
to areas of intercellular separation in the patients’ epidermis
(Fig 2h) compared to control skin (Fig 2g). However,
desmoglein 1 staining was slightly increased in intensity in the
granular layers of PkP1-null skin, however (Fig 2j), compared
to control skin (Fig 2i). This change in the staining pattern was
Figure1. Indirect immuno£uorescence with the PP1-5C2 PkP1 antibody shows staining from the basal keratinocyte layer to the granular
epidermal layers in normal skin. (a) Indirect immuno£uorescence images were digitized and selected areas within each image were chosen (indicated by
the dashed line box) to undergo image analysis. (b) Fluorescent image analysis was performed by measuring the £uorescence intensity within several se-
lected areas of epidermis (n¼ 5) from the dermal epidermal junction (distance 0%) to the upper limit of the stratum corneum (distance 100%). Staining of
multiple areas revealed that PkP1 is maximally expressed between the lower and mid suprabasal layers of control epidermis. Scale bar: 10 mm.
98 MCMILLAN ETAL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
in contrast to that for desmocollin 1, which showed stronger
staining in the upper suprabasal layers of control skin (Fig 2k)
than in PkP1-null skin (Fig 2l). No frozen skin samples were
available from the PKP1mutation carrier individual.
Ultrastructural morphometric analysis Low power elec-
tron microscopy of PkP1-de¢cient epidermis revealed a marked
separation between the keratinocytes in the lowest and mid
suprabasal layers, well beneath the granular layer (Fig 4b). The
spaces between the adjacent basal cells and granular
keratinocytes were small and similar to control epidermis (Fig
3a). Perinuclear keratin intermediate ¢lament clumps were also
restricted to the suprabasal keratinocyte layers in PkP1-null skin
(Fig 3b). PkP1-null epidermis showed evidence of mild
orthohyperkeratosis (not shown). The dermis showed little or no
in£ammatory cell in¢ltrate (not shown).
In control skin, morphometric analysis of desmosome size and
frequency showed that desmosomes were more than three times
larger in the LSB layers than in the USB layers (366.2 nm vs 114.0
nm) and marginally more frequent (5 desmosomes per HPV vs
3.9 per HPV) (Fig 4a, g vs 4d;Table II).
In PkP1-null patients, LSB epidermal keratinocytes showed
considerably reduced desmosome size and frequency, by as much
as 49% (188.4 nm vs 366.2 nm, po0.01) and 61% (1.9 vs 5.0
desmosomes per HPV, po0.01), respectively, compared to
control skin (seeTable II, Fig 4a vs 4b). The heterozygous PkP1
mutation carrier (Fig 4c,Table II) showed a smaller reduction in
desmosome size and frequency in the LSB layers: by 37% (231.6
nm vs 366.4 nm, po0.01) and 20% (4.0 vs 5.0 desmosomes per
HPV), respectively.
In the USB layers, the desmosome size and frequency in
control skin and the carrier were similar (108.3 nm vs 114.0 nm
and 3.8 vs 3.9 desmosomes per HPV, respectively; Fig 4d vs 4f).
Surprisingly, the average USB desmosome size in the PkP1-null
epidermis was similar to the patients’ LSB layer but larger than
the control USB value (Table II, Fig 4d, e). The three patients’
skin biopsies consistently showed signi¢cant increases in USB
desmosome size by 59% compared to the control value
(178.5 nm vs 114.0 nm, po0.01). The PkP1-null USB epidermal
desmosome frequency remained reduced by 43%, however,
compared to the control skin (2.2 desmosomes per HPV vs 3.8,
po0.01).
In addition to the morphometric observations, non-obliquely
sectioned control desmosomes regularly showed a clearly
de¢ned and distinct two-plaque structure (Fig 4g, arrowheads)
comprising a cell-membrane-associated dense plaque adjacent to
an electron-lucent area that, in turn, was apposed to an inner
dense plaque in close association with keratin intermediate
¢laments (as described by Legan et al, 1992; Garrod, 1993; Garrod
et al, 2002). The electron-dense extracellular mid-line was also
more prominent in control skin than in PkP1-null skin (Fig 4g,
arrows, vs Fig 4h, white arrows, respectively). In PkP1-de¢cient
skin, LSB desmosomes were small and exhibited especially
poorly de¢ned outer plaques. In all three PkP1-de¢cient patient
samples, similar ¢ndings were observed.The una¡ected mutation
carrier showed a more clearly de¢ned desmosome two-plaque
structure with prominent desmosomal mid-lines (Fig 4i,
arrowheads and arrow, respectively).
In control skin, the desmosome-associated keratin ¢laments
were often electron dense, wide and were frequently observed
connecting to thicker ¢lament bundles deeper in the cytoplasm.
Other non-desmosome sites of close keratinocyte cell^cell
association were also regularly observed including, in all layers,
small villus-like projections of the plasma membrane resembling
putative sites of adherens junctions, and in the suprabasal layers
characteristic gap-junction-like structures. In contrast, PkP1-
de¢cient skin showed a poor association between the keratin
intermediate ¢lament bundles and the desmosome inner plaque
(Fig 4b, e). Thin bundles of clumped keratin ¢laments in the
suprabasal layers were often observed with no connection to the
Figure 2. Altered expression of desmosomal components in the su-
prabasal layers of a PkP1-null patient’s skin. Bright intercellular PkP1
staining was observed at the keratinocyte periphery in control skin (a);
however, there was no staining in ectodermal dysplasia/skin fragility skin
(PkP1-null patient, case 1) (b). (The dashed lines in (b), (c), and (d) mark the
approximate position of the dermal-epidermal junction, DEJ.) Di¡use
PkP2 staining was restricted to the basal layer cytoplasm in control inter-
follicular arm skin (c) but in PkP1-null skin PkP2 showed marked inter-
cellular staining between keratinocytes in the suprabasal layers and
granular layers (d). In addition, PkP2 staining appeared more restricted to
the keratinocyte periphery in PKP1-null skin (d) compared to control skin
(c). Plakophilin 3 was present within the periphery of all keratinocyte layers
in control skin (e) and was similarly expressed but more pronounced at the
keratinocyte border in all layers of the PkP1-null patient’s skin (f). Plako-
globin staining showed an occasional focal disruption of the normal supra-
basal staining pattern in the patient’s epidermis (h) compared to control
skin (g). Desmoglein 1 labeling, however, showed an increase in staining
intensity in the granular layers of PkP1-null skin (arrowheads in j) compared
to control skin (i). This change in the staining pattern was in contrast to
that for desmocollin 1, which showed stronger staining in the upper supra-
basal layers of control epidermis (i) compared to PkP1-null skin (j).
(a),(c),(e),(g),(i),(k) Control skin; (b),(d),(f),(h),(j),(l) PkP1-null patient’s skin.
(a),(b) PkP1; (c),(d) PkP2; (e),(f) PkP3; (g), (h) plakoglobin; (i),(j) desmoglein
1; (k),(l) desmocollin 1. Scale bar: 30 mm.
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intermediate ¢lament network deeper within the keratinocyte
(Fig 4e). Keratin aggregates were often found in a perinuclear
distribution. Desmosomes were localized at the ends of thin
plasma membrane villus-like projections with a marked
widening of intercellular spaces between keratinocytes from the
¢rst suprabasal layer upwards. In PkP1-null skin, nondesmosome
Figure 3. Transmission electron microscopy of PkP1-null epidermis shows a marked disturbance in normal keratinocyte adhesion from the
¢rst suprabasal layer compared to control or the una¡ected mutation carrier skin. Low power electron microscopy of PKP1-null skin (b, case 2)
showed a dramatic separation between the keratinocytes starting in the ¢rst suprabasal epidermal layer compared to control (a) or the PKP1mutation carrier
epidermis (c). Enlarged intercellular spaces (b, asterisk) were rarely observed in either control (a) or PKP1 carrier skin (c) compared to the a¡ected indivi-
duals. In PkP1-null epidermis, keratinocyte desmosomal contacts appeared at the ends of long villus-like projections of the plasma membrane (b). Clumped
or aggregated keratin ¢lament bundles are also visible in a perinuclear distribution in the middle layers (b). Note, however, the close association between
basal keratinocytes and the melanocyte (M), as well as between the keratinocytes in the mid-suprabasal layer and the Langerhans cell (L). Scale bar: 2 mm.
Figure 4. High power electron microscopy shows a reduction in the LSB desmosomal size and frequency in the carrier and PkP1-null pa-
tients’ skin. PkP1-null epidermis LSB layers show reductions in both desmosome size and number (b) compared to control skin (a). Desmosomes also have
poor keratin ¢lament network connections (with some clumping of sparse ¢laments around the desmosomal inner plaque and a loss of the distinct two-
plaque structure) (arrowheads, h vs g). The desmosomal mid-line was more prominent in control and carrier skin than in PkP1-null skin (g, i,arrows, vs h, white
arrows). The heterozygous PKP1 mutation carrier (c) showed only mild reductions in desmosome size and number but the desmosomes showed more nor-
mal clear inner and outer plaque structure (arrowheads) observed in control samples (i and g, respectively). Desmosomes in the upper layers of control skin (d)
appeared smaller than in the lower layers (a). Surprisingly, desmosomes in the USB layers of the PkP1-null patients’ skin (e) were slightly larger but less
frequent than desmosomes in control skin (d). The average sizes of PkP1-null patient LSB and USB desmosomes were almost identical (b and e, respec-
tively). Control USB epidermal desmosomes (d) and the una¡ected carrier (f) were also similar in appearance. Normal skin: (a), (d), (g); PkP1-null patient:
(b), (e), (h); carrier: (c), (f), (i). USB, (d), (e), (f); LSB, lower power, (a), (b), (c); LSB, higher power, (g), (h), (i). Scale bars: 100 nm.
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associations (adherens-junction-like structures) were observed
and made clearer by the widening of the intercellular spaces. In
the granular layer, where keratinocyte separation was minimal,
gap-junction-like structures could be easily identi¢ed.
Epidermis from the carrier showed no widening of the
intercellular spaces (Fig 3c vs 3a) but there were reductions in
the numbers of LSB desmosomes and their size (see Table II,
po0.01). Desmosomes in the USB compartment were smaller
than the LSB desmosomes in the carrier but a similar size and
number to those in the control samples (Table II, p40.05).
Desmosome-keratin intermediate ¢lament association was
observed in the carrier (Fig 4c, f). Gap- and adherens junction-
like structures appeared normal in the PkP1 carrier epidermis.
DISCUSSION
Our results have quantitatively demonstrated that PkP1-de¢cient
desmosomes in the LSB layers are signi¢cantly smaller and less
frequent than in normal skin. The reduction in desmosome size
coincides with a dramatic loss of keratinocyte adhesion from the
¢rst suprabasal layer that con¢rms other reports of maximal PkP1
expression at precisely this level in control skin (Moll et al, 1997).
We have provided the ¢rst quantitative evidence that the function
of PkP1 is to aid desmosomal component recruitment and/or sta-
bility and hence keratin intermediate ¢lament anchorage to the
plasma membrane. From our data, we have shown that assess-
ment of desmosome size and frequency together with careful
evaluation of intercellular adhesion and desmosome^keratin ¢la-
ment association can be used as additional key diagnostic features
of this disease.
The desmosome size and frequency in PkP1-null skin LSB
layers showed reductions compared to control skin. Surprisingly,
desmosome size in PkP1-null skin failed to show the characteris-
tic di¡erentiation-induced changes compared to the controls.
Desmosomes in both LSB and USB layers in PkP1-null skin
showed similar sizes and frequencies. This may be due to an
over-compensation for the loss of cell cohesion in the LSB layers.
We hypothesize that desmosome disruption caused by the loss of
PkP1 may lead to a compensatory increase in expression of des-
moglein 1, PkP2, or PkP3 (but not desmocollin 1) in the USB
layers. Desmoglein 1 binds to members of the armadillo protein
family and these provide a link between the cadherins and the
keratin ¢laments via desmoplakin (Mathur et al, 1994; Roh and
Stanley, 1995). Other desmosomal components may also be
involved in this process; however, signi¢cant changes in their ex-
pression patterns were not observed in the USB layers of PkP1-
null skin. In the absence of PkP1, other proteins like PkP2, PkP3,
or plakoglobin may act as cytoplasmic linkers capable of stabiliz-
ing the major desmosomal components (desmoplakin, desmogle-
in 1, and desmocollin 1) and, indirectly, keratin ¢laments (Mathur
et al, 1994; Schmidt et al, 1999; Hofmann et al, 2000;Chen et al,
2002). In the absence of apparent plakoglobin upregulation in
PkP1-null epidermis, we conclude that PkP2 or PkP3 may play
a more important role in this disease.We cannot exclude a role for
plakoglobin in this process, however, for the following reason:
there might be an increase in plakoglobin recruitment to desmo-
somes from adherens junctions not detectable by immunohisto-
chemistry. The dramatic upregulation of PkP2 (but not PkP3) in
the suprabasal epidermal layers was also seen in psoriatic skin but
not in the epidermis of patients with pemphigus vulgaris. This
suggests that PkP2 expression might be associated with epidermal
hyperproliferation (as in the case of psoriasis) rather than a loss of
cell-cell adhesion or acantholysis (as in pemphigus vulgaris).
These observations con¢rm reports that one PkP2 function
might be signaling and the control of proliferation (Chen et al,
2002).
The roles PkP3 and possibly PkP4/p0071 may play in aiding
desmosomal assembly in PkP1-de¢cient keratinocytes are un-
known (Schmidt et al, 1999). Further examination of the function
of PkP3 and PkP4 in PkP1-null skin is required. PkP1 is thought
to be important in stabilizing and/or targeting multiple desmoso-
mal components into the plaque via its C-terminal globular head
domain, which is thought to interact with desmoplakin (Kowalc-
zyk et al, 1999; Hatzfeld et al, 2000; Hofmann et al, 2000; Born-
slaeger et al, 2001), desmoglein 1, desmocollin 1a (Smith and
Fuchs, 1998), and unpolymerized keratin subunits in vitro (Hatz-
feld et al, 2000). PkP1 is also thought to enhance the recruitment
of a variety of desmosomal proteins (Smith and Fuchs, 1998; Ko-
walczyk et al, 1999; Hatzfeld et al, 2000) due to its central position
in the outer plaque of the desmosome (North et al, 1999). Desmo-
glein 1 (Smith and Fuchs, 1998; Hatzfeld et al, 2000; Hofmann
et al, 2000) and desmocollin 1a (Smith and Fuchs, 1998) appear
to be the most important transmembrane binding partners for
PkP1 and, interestingly, both show strong staining in the supra-
basal epidermal layers (Amagai et al, 1995; 1996), precisely where
the most severe loss of cell adhesion occurs in PkP1-de¢cient epi-
dermis (McGrath et al, 1997; 1999b; Hamada et al, 2002) and where
PkP1 expression was at its highest in control skin. Transgenic
mice with a conditional epidermal knockout for desmoplakin
formed apparently normal desmosomes that only lacked keratin
¢lament connections (Vasioukhin et al, 2001). The epidermis of
these mice showed a loss of cell cohesion, however, again in the
mid-epidermal layers, that was similar to that observed in PkP1-
null skin. Desmoplakin-null keratinocytes formed albeit sparse
and weak desmosomekeratin links that suggests that other
molecules including PkP1 might play a role in desmosome
keratin recruitment or stabilization (Green and Gaudry, 2000;
Table II. Morphmetric measurement results highlighting a reduction in desmosome size and number in all epidermal layers in
PkP1-null skin compared to control skin
LSB keratinocytes USB keratinocytes
Sample reference,
age at biopsy
Number of
individuals
Desmosome size
(nm, mean7SEM)
Desmosome
number
(per HPV,b mean7SEM)
Desmosome size
(nm, mean7SEM)
Desmosome number
(per HPV, mean7SEM)
Control skin 5 366.276.90 5.070.19 114.073.19 3.970.21
PkP1-null case 1, 5 y, IIF, EM 1 173.378.12 1.870.12 164.376.74 2.070.14
PkP1-null case 2, 2 y, IIF, 5 y EM 1 197.279.47 1.970.13 184.776.22 2.370.18
PkP1-null case 3, 5 y, EM 1 195.0711.01 2.070.12 205.179.40 2.770.21
PkP1-null case 3, 17 y, IIF, EM 1 167.977.47 2.370.16 174.5711.45 2.270.24
Mean PkP1-null patients’ values 4 178.275.40a 2.170.05a 178.575.19a 2.270.08a
Case 3 healthy sibling (mutation carrier), 15 y 1 231.679.59a 4.070.33a 108.374.10 3.870.25
aDenotes a po0.01 compared to the control value (Mann-Whitney and ANOVA tests).
bHPV, high power view; IIF, indirect immuno£uorescence (age at biopsy); EM, electron microscopy (age at biopsy).
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Vasioukhin et al, 2001). This may account for the poor
desmosome^keratin associations in PkP1-null patients.
Control epidermal desmosome size and frequency varies be-
tween di¡erent epidermal layers (Snell, 1966; Allen and Potten,
1975; Raknerud, 1975; Hino et al, 1981;Wan et al, in press ). It has
been reported that the average human epidermal desmosome size
ranges between 300 and 400 nm (Wan et al, in press; Hino et al,
1981), similar to our LSB control skin values. In addition, our
¢ndings of desmosome size reductions in control skin USB layers
compared to LSB layers agree with previous reports (Snell, 1965;
Raknerud, 1975; Caputo and Peluchetti, 1977). One report has ad-
dressed the desmosome size variations between human body sites,
e.g., palm versus breast skin (Wan et al, in press), but none has ad-
dressed either age or sex di¡erences.
We have demonstrated that a single heterozygous PkP1 muta-
tion carrier also shows a measurable, although smaller, decrease in
LSB desmosome size and number. This is despite this carrier
showing any detectable clinical symptoms. Residual PkP1 ex-
pression in the carrier therefore causes only a mild reduction in
desmosome size and numbers in the LSB layers. This quantitative
reduction is apparently compensated for by su⁄cient keratinocyte
adhesion. Thus, having only one functional PkP1 allele does not
lead to disease in this case.
We hypothesize that the basal and granular keratinocyte layers
were spared from a loss of keratinocyte adhesion because of sev-
eral factors. First, within the basal layers, desmosomes are known
to be sparse (Hino et al, 1981) and basal keratinocytes express a
range of molecules speci¢cally implicated in nondesmosomal cell
adhesion, e.g., the classical cadherins (including E-cadherin) and
b1-associated integrin members (Schmidt et al, 1994; Jensen and
Wheelock, 1995). Consequently, the expression of PkP1 in the ba-
sal layer and several of its binding partners, including desmoglein
1 and desmocollin 1, is weak or altogether absent (Amagai et al,
1995; Smith and Fuchs, 1998). The granular and corni¢ed cell
layers were also spared from a loss of cell adhesion. Normal adhe-
sion in these layers may be due to the presence of other adhesion
junctions between keratinocytes including granular layer tight
junctions that may provide alternative mechanisms of intercellu-
lar adhesion (Furuse et al, 2002; Morita et al, 2002). The lipid and
corni¢ed cell envelope in the upper layers may also play a role in
compensating for the loss of desmosome cell adhesion by stabi-
lizing desmosomes at the keratinocyte periphery (Akiyama et al,
1999).
The cause of the hyperkeratosis observed in this condition is
unknown. PkP1 expression has been con¢rmed throughout all
layers of the human epidermis except the stratum corneum (Moll
et al, 1997).We previously highlighted abnormal, persistent keratin
14 expression in the USB layers and the redistribution of desmo-
plakin from the desmosomal plaque into the cytoplasm in the
¢rst and subsequent cases (McGrath et al, 1997; 1999a). A PkP1-
null keratinocyte cell line showed altered keratinocyte migration
and cell-ceell adhesion but no change in the proliferative rate
compared to controls.2 The redistribution of desmoplakin within
the keratinocyte cytoplasm may account for the poor ultrastruc-
tural keratin-desmosome attachment observed in these cases and
attests to the role of PkP1 in cytoskeletal organization and/or de-
gradation. A combination of these changes or an over-compensa-
tory increase in desmosome size might be responsible for this
abnormal keratinization, leading to acral hyperkeratosis, the ma-
jor clinical problem in this condition (Whittock et al, 1999).
In conclusion, we have demonstrated evidence of a compensa-
tory mechanism enlarging desmosome plaque size in the upper
layers of the stratum spinosum to correct for the loss of cell adhe-
sion in the lower layers and suggested candidate molecules for
mediating these changes. These ¢ndings will enable further
detailed study of the mechanisms controlling keratinocyte adhe-
sion and the processes of corni¢cation in both normal epidermis
and the diseased state.
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